Furthermore, PCs are generally slow growing, and even if patients with PC are false negatively classified as low risk by a genetic prediction model, they can still be followed with serial PSA measurements, and can have prostate biopsy with increasing PSA before reaching advanced stages except in rare cases of very aggressive tumor. Here, KLK3 is linked to neoplasm.